R Kubin

Randomized Controlled Trial of Sequential Intravenous (i.v.) and Oral Moxifloxacin Compared with Sequential i.v. and Oral Co-Amoxiclav with or without Clarithromycin in Patients with Community-Acquired Pneumonia Requiring Initial Parenteral Treatment

R. Finch, Dirk Schürmann, Owen Collins et al. · Antimicrobial Agents and Chemotherapy · 2002 · 184 citations · Full text

Community-acquired Pneumonia, Oral Moxifloxacin Compared, Oral Co-amoxiclav +12

Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitis

Robert J. Wilson, R Kubin, Ian Ballin et al. · Journal of Antimicrobial Chemotherapy · 1999 · 167 citations

Effectiveness of oral moxifloxacin in standard first-line therapy in community-acquired pneumonia

Antoni Torres, J-F Muir, Paul Corris et al. · European Respiratory Journal · 2003 · 88 citations · Full text

An Economic Evaluation of Sequential IV/po Moxifloxacin Therapy Compared to IV/po Co-amoxiclav With or Without Clarithromycin in the Treatment of Community-Acquired Pneumonia*

Michael Drummond, Debbie Becker, Margaret Hux et al. · CHEST Journal · 2003 · 53 citations

Antibiotics, Healthcare-associated Infection, Iv/po Co-amoxiclav +7

Moxifloxacin and Glucose Homeostasis

James R. Gavin, R Kubin, Shurjeel Choudhri et al. · Drug Safety · 2004 · 40 citations

Metabolic Syndrome, Physiology, Diabetes +6